Stent News and Research

RSS

A stent is a small mesh tube that’s used to treat narrowed or weakened arteries in the body.

You may have a stent placed in an artery as part of a procedure called angioplasty (AN-jee-oh-plas-tee). Angioplasty can restore blood flow through narrowed or blocked arteries. Stents help prevent arteries from becoming narrowed or blocked again in the months or years after treatment with angioplasty. You may also have a stent placed in a weakened artery to improve blood flow and to help prevent the artery from bursting.

Stents are usually made of metal mesh, but sometimes they’re made of fabric. Fabric stents, also called stent grafts, are used in larger arteries. Some stents are coated with medicines that are slowly and continuously released into the artery. These medicines help prevent the artery from becoming blocked again.

Cardiologists question FDA recommendations on genetic testing before taking Plavix

Which antiplatelet medication is best after a coronary stent? The costly and potential life-or-death question lingers after most of the 600,000 angioplasties performed every year in the United States. The answer may lie in your genes, but professional cardiovascular societies and many working cardiologists question the U.S. Food and Drug Administration's recent recommendation that patients undergo genetic testing before taking Plavix (clopidogrel bisulfate).

14 Nov 2013

Results of Nordic-Baltic Bifurcation IV trial presented at TCT 2013

A new clinical trial shows that a two-stent technique for treatment of bifurcation lesions with a large stenotic side branch was not associated with significant improved outcomes compared to a provisional stenting approach.

31 Oct 2013

New strategy for emergency anticoagulant treatment for patients with myocardial infarction

A new strategy for emergency anticoagulant treatment for patients with acute myocardial infarction has been put in place by a team led by Philippe-Gabriel Steg at Inserm Unit 698 (Haemostasis, Bioengineering, Immunopathology and Cardiovascular Remodelling), at H-pital Bichat, AP-HP, Universit- Paris Diderot).

31 Oct 2013

Wrist artery for coronary angioplasty may benefit women at high risk of blood loss

For women who are at high risk of blood loss, using an artery in the wrist may be better than the groin for routing a stent to the heart during coronary angioplasty, according to researchers at Duke Medicine.

30 Oct 2013

Mount Sinai cardiologists use FDA-approved device for severely calcified coronary arteries

Leading interventional cardiologists at The Mount Sinai Hospital are the first in the world to use a newly U.S. Food and Drug Administration approved device for the treatment of severely calcified coronary arteries before the placement of a cardiac stent to open a blocked artery.

29 Oct 2013

Stroke prevention study: Medication plus lifestyle changes safe, effective than surgical interventions

The final results of a stroke prevention study in patients with narrowed brain arteries confirm earlier findings: Medication plus lifestyle changes are safer and more effective at preventing stroke than a surgical technique called stenting.

28 Oct 2013

Transcatheter Technologies reports first-in-human implantation of transapical TRINITY aortic valve

Transcatheter Technologies GmbH, a emerging medical device company that is developing a next-generation transcatheter aortic heart valve prosthesis, announced today the successful first-in-human implantation of its transapical TRINITY aortic valve designed to be the world's best repositionable heart valve.

25 Oct 2013

Tissue-engineered transplants safe and effective in the long term: Study

New results published in The Lancet today [Wednesday 23 October] reveal that five years after the first successful transplantation of a tissue-engineered airway (reported in The Lancet in 2008) the recipient continues to enjoy a good quality of life, and has not experienced any immunological complications or rejection of the implanted airway.

23 Oct 2013

STSI receives $29M grant to support innovative research on genomics, wireless technology and bioinformatics

The National Institutes of Health has renewed its prestigious Clinical and Translational Science Award (CTSA) with the Scripps Translational Science Institute (STSI) in the amount of $29 million over the next five years to support innovative research in genomics, wireless technology and bioinformatics toward individualizing medicine.

23 Oct 2013

CSI receives PMA approval to market Diamondback 360 Coronary Orbital Atherectomy System

Cardiovascular Systems, Inc., today announced that it has received PMA approval from the U.S. Food and Drug Administration to market its Diamondback 360® Coronary Orbital Atherectomy System (OAS) as a treatment for severely calcified coronary arteries.

22 Oct 2013

Endoscopic ultrasound-guided drainage improves outcomes in patients with pseudocysts

Researchers report that in patients with pseudocysts with viscous debris-laden fluid, endoscopic ultrasound-guided drainage by using a combination of a nasocystic drain and transmural stents improves clinical outcomes and lowers the stent occlusion rate compared with those who underwent drainage via stents alone.

22 Oct 2013

New England publishes results of phase III clinical trial of ABRAXANE for metastatic pancreatic cancer

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation , today announced the results of the MPACT phase III clinical trial of ABRAXANE® in combination with gemcitabine were published online in the October 16th edition of the New England Journal of Medicine.

17 Oct 2013

Coronary artery bypass graft surgery provides better health status, quality of life in diabetic patients

For patients with diabetes and coronary artery disease in more than one artery, treatment with coronary artery bypass graft surgery provided slightly better health status and quality of life between 6 months and 2 years than procedures using drug-eluting stents, although beyond 2 years the difference disappeared, according to a study in the October 16 issue of JAMA.

16 Oct 2013

Six-month surgery delay ‘acceptable’ after DES implantation

The recommendation to delay noncardiac surgery for a year after receipt of a drug-eluting stent, compared with just 6 weeks for a bare-metal stent, may be too conservative, suggests research indicating that stent type does not influence the longer term risk for major adverse cardiac events.

14 Oct 2013

Crospon's EsoFLIP balloon dilation catheter gets FDA clearance

Crospon has today announced that it has received FDA clearance for its EsoFLIP balloon dilation catheter. This is the first product the in what will be a suite of dilation catheter products to be used for dilation procedures in the esophagus and colon. It represents the company's first foray into the therapeutic endoscopy accessory market.

11 Oct 2013

Stent News and Research

Further Reading

Cardiologists question FDA recommendations on genetic testing before taking Plavix

Results of Nordic-Baltic Bifurcation IV trial presented at TCT 2013

New strategy for emergency anticoagulant treatment for patients with myocardial infarction

Wrist artery for coronary angioplasty may benefit women at high risk of blood loss

Mount Sinai cardiologists use FDA-approved device for severely calcified coronary arteries

Stroke prevention study: Medication plus lifestyle changes safe, effective than surgical interventions

Transcatheter Technologies reports first-in-human implantation of transapical TRINITY aortic valve

Tissue-engineered transplants safe and effective in the long term: Study

STSI receives $29M grant to support innovative research on genomics, wireless technology and bioinformatics

CSI receives PMA approval to market Diamondback 360 Coronary Orbital Atherectomy System

Endoscopic ultrasound-guided drainage improves outcomes in patients with pseudocysts

New England publishes results of phase III clinical trial of ABRAXANE for metastatic pancreatic cancer

Coronary artery bypass graft surgery provides better health status, quality of life in diabetic patients

Six-month surgery delay ‘acceptable’ after DES implantation

Crospon's EsoFLIP balloon dilation catheter gets FDA clearance

Bluhm Institute enrolls first patient in SALUS trial to evaluate movable, non-metallic heart valve

Auckland physician performs first patient implant of Boston Scientific Innova DES System

Noncardiac surgery after recent coronary stent linked with increased risk of adverse cardiac events

CRF to present groundbreaking clinical trial findings at TCT 2013 scientific symposium

Novel paper-clip sized device used to tackle resistant high blood pressure

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News